YTHDF

(YTH) domain-containing family proteins (YTHDFs) are a class of cytoplasmic m6A-binding proteins characterized by the vertebrate YTH domain, which enables them to regulate RNA fate extensively. The YTH domain serves as the basis for specific recognition of m6A-modified RNA. As the most studied "readers" of m6A, the YTHDF family includes YTHDF1, YTHDF2, and YTHDF3. YTHDF1 promotes RNA translation, while YTHDF2 facilitates RNA decay. YTHDF3 exhibits a dual function that depends on its binding partner. Upon entering the cytoplasm, m6A-modified mRNAs are initially bound by YTHDF3 or a YTHDF3-YTHDF1 complex, followed by recognition by YTHDF2, thereby directing the diverse fates of the targeted mRNA. The YTHDF family plays a significant role in mediating tumor proliferation, metastasis, metabolism, drug resistance, and immunity. Moreover, they possess potential as predictive and therapeutic biomarkers[1].

共 10种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
DC-Y13-27

DC-Y13-27 是一种 DC-Y13 衍生物和 YTHDF2 抑制剂 (KD: 37.9 μM),可抑制 YTHDF2、恢复 FOXO3 和 TIMP1 蛋白水平并降低 MMP1/3/7/9 表达,诱导焦亡 (Pyroptosis) 并增加 IL-1β 分泌,从而减轻椎间盘退变、增强结肠癌和黑色素瘤对放疗的响应,并对乳腺癌具有抗肿瘤活性。

Inhibitor
99.52%
DC-Y13-27
PROTAC FTO degrader 1

PROTAC FTO degrader 1 是一种脂肪量和肥胖相关蛋白 (FTO) 的 PROTAC 降解剂,依赖 VHL E3 连接酶和泛素-蛋白酶体系统选择性降解 FTO,可增加与核糖体生物发生相关的 mRNA 上的 m6A 修饰并促进其由 YTHDF2 介导的降解,能够抑制癌细胞增殖并诱导凋亡 (apoptosis),可用于癌症研究如急性髓系白血病 (AML)(粉色:Fat Mass and Obesity-associated Protein (FTO) 配体 (MS-W20701);蓝色:VHL 配体 (MS-R95960);黑色:连接子 (MS-J83191))。

Inhibitor
PROTAC FTO degrader 1
SKLB-Y13

SKLB-Y13 是一种选择性 YTHDF1 抑制剂,IC50 为 0.76 μM,Kd 为 5.097 μM,它通过结合 YTHDF1 m6A 结合口袋中的 Tyr397 和 Trp470 残基来破坏 YTHDF1 与 m6A 修饰 mRNA 的相互作用,从而抑制癌细胞增殖并促进细胞凋亡 (apoptosis),可用于乳腺癌相关研究。

Inhibitor
98.44%
SKLB-Y13
TAE648
TL13-87

TAE648 是一种用于 PROTAC 的靶蛋白配体 (Ligand for Target Protein for PROTAC),可用于合成 PROTAC SK-3-91 (MS-X82503),并能降低单层培养的 SKOV3ip1 细胞活力。

2769753-10-6
Inhibitor
99.50%
TAE648
YTH-IN-1

YTH-IN-1(化合物 N-7)是一种泛 YTH 结构域抑制剂,对人 YTHYTHDF1、YTHYTHDF2、YTHYTHDF3、YTHYTHDC1 和 YTHYTHDC2 的 IC50 值分别为 39 μM、34 μM、35 μM、48 μM 和 30 μM。

2189366-92-3
Inhibitor
98.66%
YTH-IN-1
YTH-IN-2

YTH-IN-2 是一种 IC50 为 16.84 μM 的 YTHDC2 YTH 结构域抑制剂,可作为前体化合物用于发现高效、选择性强且具有细胞活性的 YTHDC2 小分子抑制剂。

86886-76-2
Inhibitor
YTH-IN-2
YTHDF1 Human Pre-designed siRNA Set A

YTHDF1 Human Pre-designed siRNA Set A 包含针对 YTHDF1(Human)基因不同区域设计的三对 siRNA,以及阴性对照、FAM 标记阴性对照和阳性对照。

Inhibitor
YTHDF1 Human Pre-designed siRNA Set A
YTHDF2 Human Pre-designed siRNA Set A

YTHDF2 Human Pre-designed siRNA Set A 包含针对 YTHDF2(Human)基因不同区域设计的三对 siRNA,以及阴性对照、FAM 标记阴性对照和阳性对照。

Inhibitor
YTHDF2 Human Pre-designed siRNA Set A
YTHDF2-IN-1

YTHDF2-IN-1(Compound CK-75)是一种选择性 YTHDF2 抑制剂(Kd = 26.2 μM),可结合 YTHDF2 YTH 结构域上的一个疏水性小口袋,破坏 YTHDF2 与 m6A 修饰 RNA 之间的相互作用,诱导细胞周期阻滞和细胞凋亡 (Apoptosis),并可用于慢性髓系白血病、结肠癌和胎盘绒毛癌研究。

Inhibitor
99.42%
YTHDF2-IN-1
YTHDF3 Human Pre-designed siRNA Set A

YTHDF3 Human Pre-designed siRNA Set A 包含针对 YTHDF3 (Human) 基因不同区域设计的三对 siRNA,以及阴性对照、FAM 标记阴性对照和阳性对照。

Inhibitor
YTHDF3 Human Pre-designed siRNA Set A

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础